Neuronetics Inc. (STIM)
Company Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally.
The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder.
Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.
The company sells its products through its sales and customer support team to psychiatrists.
Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
| Country | United States |
| IPO Date | Jun 28, 2018 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 716 |
| CEO | Keith J. Sullivan |
Contact Details
Address: 3222 Phoenixville Pike Malvern, Pennsylvania United States | |
| Website | https://www.neurostar.com |
Stock Details
| Ticker Symbol | STIM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001227636 |
| CUSIP Number | 64131A105 |
| ISIN Number | US64131A1051 |
| Employer ID | 00-0000000 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Keith J. Sullivan | President, Chief Executive Officer & Director |
| Cory S. Anderson | SVice President & Chief Technology Officer |
| Lisa Metzner-Rosas | Senior Vice President & Chief Marketing Officer |
| Dr. Geoffrey Garland Grammer M.D. | Chief Medical Officer |
| Rusty Page | SVice President & Chief Information and Operations Officer |
| Sara Grubbs | Senior Vice President & Chief Revenue Officer |
| William P. Leonard | Chief Clinic Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 10, 2025 | DEFA14A | Filing |
| Apr 10, 2025 | DEF 14A | Filing |
| Mar 27, 2025 | 10-K | Annual Report |
| Mar 27, 2025 | PRE 14A | Filing |
| Mar 27, 2025 | 8-K/A | [Amend] Current Report |
| Mar 13, 2025 | 4/A | [Amend] Filing |
| Mar 13, 2025 | 4/A | [Amend] Filing |
| Mar 13, 2025 | 4/A | [Amend] Filing |
| Mar 06, 2025 | 4 | Filing |
| Mar 06, 2025 | 4 | Filing |